Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

PhRMA Statement on Senate Passage of PDUFA VI Reauthorization

August 3, 2017

PhRMA applauds the Senate for passage of the Prescription Drug, Biosimilar and Generic Drug User Fee Acts.

Read More

New Report Shows 74 Percent of Medicines in Development have Potential to be First-in-Class Treatments

July 18, 2017

Seventy-four percent of medicines in clinical development around the world are potentially first-in-class medicines, meaning they use a completely new approach to fighting a disease, according to a new report.

Read More

PhRMA Statement on House Passage of PDUFA VI Reauthorization

July 12, 2017

PhRMA president and CEO Stephen J. Ubl issued the following statement on the House passage of PDUFA reauthorization.

Read More

More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention

June 27, 2017

America’s biopharmaceutical companies are continuing the fight to conquer the human immunodeficiency virus (HIV), which can develop into acquired immune deficiency syndrome (AIDS), with 52 medicines and vaccines currently in development to help treat and prevent the infection, according to a report released today by PhRMA in partnership with The AIDS Institute.

Read More

Aspen Spotlight Health 360° VIDEO PREMIERE:
New Virtual Reality Video Takes You Inside The Lab with Researchers to Showcase Amazing Advancements in Medicine

June 22, 2017

America’s biopharmaceutical companies released a new virtual reality video highlighting innovation and a new era of groundbreaking advancements today to kick off Spotlight Health, the opening segment of the annual 2017 Aspen Ideas Festival.

Read More

Nuevos Informes Destacan el Aumento de la Competencia Global en I + D Biofarmacéutica, Planteando Desafíos Significativos para la Futura Posición de Estados Unidos

June 5, 2017

Mientras los Estados Unidos buscan mantener su liderazgo mundial en la investigación y el desarrollo biofarmacéutico, tres nuevos informes apuntan a un entorno global cada vez más competitivo.

Read More

New Reports Highlight Increasing Global Competition in Biopharmaceutical R&D, Posing Significant Challenges to Future U.S. Standing

June 5, 2017

As the U.S. looks to maintain its global leadership in biopharmaceutical research and development, three new reports point to an increasingly competitive global environment.

Read More

New Report Shows More than 240 Immuno-Oncology Treatments in Development for Patients with Cancer

June 1, 2017

A new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA) in partnership with The American Cancer Society Cancer Action Network (ACS CAN) finds there are more than 240 immuno-oncology medicines and vaccines currently in development.

Read More

PhRMA Statement on Intellectual Property Enforcement Coordinator

May 24, 2017

PhRMA released the following statement on the appointment of Vishal Amin as Intellectual Property Enforcement Coordinator.

Read More